Retinal Consultants - RetinalMD.com

07/22/2025

ZEISS CLARUS 700 has received approval in China, bringing advanced retinal imaging to eye care providers. With ultra-widefield, high-resolution images and AI-enhanced tools, this device helps doctors diagnose and monitor retinal diseases more precisely than ever. Learn more: https://brnw.ch/21wUlts

CLARUS 700, the advanced retinal imaging system, captures 133 degrees in a single image and up to 267 degrees with multiple images.

07/17/2025

Meet Dr. Eliot Dow, MD, PhD, an accomplished retina specialist with a passion for combining advanced research and personalized care. Trained at top institutions including Cornell, UCLA, and Duke, Dr. Dow brings a unique blend of clinical excellence and innovation to Retinal Consultants Medical Group. Now accepting new patients! Learn more: https://brnw.ch/21wUdJX

07/15/2025

Gore has launched a new silicone-free 0.5-mL IMPROJECT plunger for eye injections, helping reduce risks like floaters, inflammation, and high eye pressure linked to silicone. This new design meets strict safety standards and could make treatments even safer for patients receiving retinal and ophthalmic medications. Learn more: https://brnw.ch/21wUaF3

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance clinical and patient care.

07/09/2025

July Image of the Month: Gyrate Atrophy, provided by Joseph Kraus at California Retina Consultants.

In this fluorescein angiogram of a patient with gyrate atrophy, we see the choroidal circulation in exquisite detail because the overlying retina and choroid have degenerated. Gyrate Atrophy is caused by a rare autosomal recessive mutation that causes a deficiency of ornithine aminotransferase. Loss of this enzyme leads to toxic build up of ornithine in the choroid and retina. There is no cure for gyrate atrophy, though treatments that lower ornithine levels by restricting arginine or supplementing vitamin B6.

Keep an EYE out for next month's featured image!

07/04/2025

Our offices will be closed on Thursday, July 4, in observance of Independence Day. 🇺🇸 We wish all our patients, staff, and community a safe and joyful holiday - please celebrate responsibly and protect your vision around fireworks!

07/02/2025

Fireworks may light up the sky, but they also send thousands to the ER each year, especially around the 4th of July. Eye injuries, burns, and serious trauma are common, particularly in kids. This Fireworks Safety Week (June 28–July 4), skip backyard fireworks and keep celebrations safe - your child's sight depends on it.

06/26/2025

Dr. David Cupp brings precision and compassion to every patient he treats. With elite training from UCLA’s Jules Stein Eye Institute and expertise in macular degeneration, diabetic retinopathy, and retinal detachment, he’s also contributed to groundbreaking research in stem cell therapy and nerve growth. Patients trust him not just for his skill, but for the time and care he gives every visit. Learn more: https://brnw.ch/21wTHyn

06/24/2025

The FDA has granted Breakthrough Therapy Designation to Tinlarebant for Stargardt disease, based on promising phase 3 trial results. This designation highlights its potential to become the first approved treatment for this serious, currently untreatable eye condition. Learn more: https://brnw.ch/21wTEDd

The designation is based off previously reported phase 3 data from the ongoing DRAGON trial.

06/19/2025

Ashvattha Therapeutics announced encouraging phase 2 results for migaldendranib, a new subcutaneous treatment for wet AMD and diabetic macular edema. Patients saw major reductions in eye injection frequency—up to five times less—and improvements in vision, with no serious side effects reported. Learn more: https://brnw.ch/21wTxw9

Ashvattha Therapeutics reveals promising phase 2 results for migaldendranib, showcasing significant improvements in retinal disease treatment and reduced injection burden.

06/17/2025

What are the earliest signs that diabetic retinopathy is affecting your retina? In the beginning, you may not notice any symptoms, but tiny blood vessels in the retina can become twisted or leak, leaving small spots of blood. This is called nonproliferative diabetic retinopathy, and if left unchecked, it can progress to more serious forms or lead to diabetic macular edema, which blurs vision and can cause permanent damage. Regular eye exams are essential for catching these changes early and protecting your sight.

06/12/2025

Dr. Nakul Singh joined Retinal Consultants Medical Group in 2024, driven by a fascination with the retina and a passion for helping people protect their vision. From advanced treatments to meaningful patient connections, he says being a retina specialist is “the best job in the world.” Learn more about Dr. Singh and his advice for diabetic eye care in Sactown Magazine's recent feature: https://brnw.ch/21wTlKh

Nakul Singh, M.D. Retinal Consultants Medical Group Dr. Singh is board-certified by the American Board of Ophthalmology and is an active member of the American Academy of Ophthalmology and the American Society of Retina Specialists. He joined Retinal Consultants in September 2024. What made you want...

06/11/2025

June Image of the Month: Asteroid Hyalosis, provided by Inara Pimentel at Vitreoretinal Consultants.

No this isn't a snow globe, but asteroid hyalosis! Asteroid Hyalosis is characterized by calcium-lipid asteroid bodies that are suspended in the collagen fibrils of the vitreous. We aren't entirely sure what causes asteroid hyalosis, but it is almost always a benign process and surprisingly, does not cause visual disturbance. Very rarely is any intervention necessary to treat this process. While it is fun to look at, it can make accurate examination and imaging of the retina more challenging.

Keep an EYE out for next month's featured image!